Last update at 2025-06-13T16:46:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Fri 16 May 25, 01:40 PMEncompass Health to Expand Florida Presence With New 50-bed Facility
Tue 13 May 25, 12:28 PMAveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook
Thu 08 May 25, 10:30 AMAveanna to Participate at the RBC 2025 Global Healthcare Conference
Tue 29 Apr 25, 11:30 AMEncompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Mon 28 Apr 25, 01:15 PMAveanna to Participate at the Bank of America Securities 2025 Health Care Conference
Tue 22 Apr 25, 11:30 AMAveanna Announces First Quarter 2025 Earnings Release Date and Conference Call
Thu 17 Apr 25, 10:30 AMCentene Extends SilverSummit's Presence to the Edges of Nevada
Fri 11 Apr 25, 03:46 PMAveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skilled Pediatric Care
Thu 03 Apr 25, 11:30 AMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -663.81400M | -113.57600M | -51.73400M | -75.03000M | -49.65900M |
Minority interest | - | - | - | - | - |
Net income | -662.03400M | -117.04400M | -57.05000M | -76.51600M | -47.14600M |
Selling general administrative | 483.95M | 427.77M | 354.77M | 341.00M | 321.84M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 553.23M | 542.40M | 454.51M | 419.25M | 394.32M |
Reconciled depreciation | 38.82M | 35.39M | 30.22M | 27.01M | 11.94M |
Ebit | 26.30M | 95.97M | 81.95M | 38.95M | 41.46M |
Ebitda | 65.12M | 131.36M | 112.17M | 71.80M | 53.40M |
Depreciation and amortization | 38.82M | 35.39M | 30.22M | 32.84M | 11.94M |
Non operating income net other | 86.18M | -8.53500M | - | - | - |
Operating income | 26.30M | 95.97M | 81.95M | 38.95M | 39.03M |
Other operating expenses | 1754.48M | 1584.19M | 1413.30M | 1322.45M | 1199.06M |
Interest expense | 99.94M | 68.93M | 82.98M | 92.30M | 75.54M |
Tax provision | -1.78000M | 3.47M | 5.32M | 1.49M | -2.51300M |
Interest income | 0.68M | 0.25M | 0.34M | 0.21M | 0.59M |
Net interest income | -107.04100M | -68.67700M | -82.63800M | -92.08900M | -74.94800M |
Extraordinary items | - | - | - | - | - |
Non recurring | 675.45M | 130.53M | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | -1.78000M | 3.47M | 5.32M | 1.49M | -2.51300M |
Total revenue | 1787.64M | 1678.62M | 1495.11M | 1384.07M | 1253.67M |
Total operating expenses | 520.06M | 447.98M | 372.71M | 357.64M | 339.71M |
Cost of revenue | 1234.42M | 1136.21M | 1040.59M | 964.81M | 859.35M |
Total other income expense net | -690.11900M | -209.54300M | -133.68500M | -113.98400M | -29.32100M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -662.03400M | -117.04400M | -57.05000M | -76.51600M | -47.14600M |
Net income applicable to common shares | -662.03400M | -117.04400M | -57.05000M | -76.51600M | -47.14600M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 1637.16M | 1711.76M | 2334.37M | 1844.02M | 1578.43M |
Intangible assets | 94.01M | 95.86M | 102.85M | 73.57M | 54.30M |
Earning assets | - | - | - | - | - |
Other current assets | 25.14M | 9.81M | 9.20M | 11.34M | 8.56M |
Total liab | 1764.60M | 1715.93M | 1696.42M | 1576.85M | 1307.49M |
Total stockholder equity | -129.57000M | -4.17500M | 637.95M | 267.17M | 270.94M |
Deferred long term liab | - | 3.84M | 3.05M | 3.80M | 0.80M |
Other current liab | 141.59M | 249.58M | 129.00M | 149.63M | 3.42M |
Common stock | 1.91M | 1.89M | 1.85M | 1.42M | 1.37M |
Capital stock | 1.91M | 1.89M | 1.85M | 1.42M | 1.37M |
Retained earnings | -1371.23400M | -1236.71000M | -574.67600M | -457.63200M | -400.58200M |
Other liab | - | 62.54M | 64.35M | 82.57M | 54.42M |
Good will | 1054.55M | 1159.69M | 1835.58M | 1316.38M | 1226.06M |
Other assets | - | 27.36M | 33.36M | 34.55M | 31.26M |
Cash | 43.94M | 19.22M | 30.49M | 137.34M | 3.33M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 354.76M | 326.50M | 344.83M | 260.41M | 168.54M |
Current deferred revenue | - | 3.84M | 135.96M | 29.44M | 77.85M |
Net debt | 1455.25M | 1336.13M | 1267.95M | 1091.06M | 1076.31M |
Short term debt | 183.04M | 28.45M | 27.25M | 24.67M | 20.86M |
Short long term debt | 13.15M | 15.38M | 13.71M | 2.87M | 2.03M |
Short long term debt total | 1499.19M | 1355.35M | 1298.44M | 1228.40M | 1079.64M |
Other stockholder equity | 1237.62M | 1230.65M | 1210.78M | 723.38M | 670.16M |
Property plant equipment | - | 22.75M | 31.37M | 78.87M | 80.47M |
Total current assets | 314.89M | 269.75M | 279.21M | 340.64M | 186.34M |
Long term investments | - | - | - | - | - |
Net tangible assets | - | -1259.72600M | -1300.48000M | -1122.78800M | -1009.41900M |
Short term investments | - | - | - | - | - |
Net receivables | 245.81M | 225.63M | 225.29M | 180.88M | 164.30M |
Long term debt | 1276.34M | 1281.08M | 1226.52M | 1163.49M | 31.50M |
Inventory | - | 15.09M | 14.23M | 11.08M | 10.16M |
Accounts payable | 30.13M | 44.62M | 52.62M | 56.67M | 66.42M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 2.13M | - | - | -31.29300M | -20.62200M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | 1.89M | 1.85M | 1.42M | 1.37M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | -1236.71000M | -574.67600M | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 4.67M | 105.26M | 33.36M | 7.63M | 5.19M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 1322.28M | 1442.01M | 2055.16M | 1503.37M | 1392.09M |
Capital lease obligations | 54.70M | 58.89M | 58.22M | 52.13M | 51.99M |
Long term debt total | - | 1281.08M | 1226.52M | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -11.72500M | 1.03M | -193.54400M | -17.82400M | -229.54700M |
Change to liabilities | 3.50M | -23.61200M | -6.81100M | 19.29M | 21.51M |
Total cashflows from investing activities | -25.29100M | -681.83100M | -193.54400M | -17.82400M | -229.54700M |
Net borrowings | 68.10M | 1416.85M | 166.13M | 68.94M | 149.73M |
Total cash from financing activities | 62.42M | 586.33M | 210.94M | 21.86M | 204.15M |
Change to operating activities | -35.07100M | -50.82200M | 54.78M | -9.56900M | 21.20M |
Net income | -662.03400M | -117.04400M | -57.05000M | -76.51600M | -47.14600M |
Change in cash | -11.27300M | -106.85500M | 134.02M | -4.67400M | -3.79800M |
Begin period cash flow | 30.49M | 137.34M | 3.33M | 8.00M | 11.80M |
End period cash flow | 19.22M | 30.49M | 137.34M | 3.33M | 8.00M |
Total cash from operating activities | -48.40200M | -11.35000M | 116.62M | -8.71400M | 21.60M |
Issuance of capital stock | 0.00000M | 477.69M | 50.00M | 0.00000M | 54.42M |
Depreciation | 38.82M | 35.39M | 30.22M | 27.01M | 11.94M |
Other cashflows from investing activities | -13.56600M | -681.83100M | -681.83100M | -681.83100M | -681.83100M |
Dividends paid | - | - | - | - | - |
Change to inventory | - | -27.05800M | 3.48M | -13.19500M | 15.40M |
Change to account receivables | -3.22700M | -8.80800M | 8.56M | 3.34M | -7.95500M |
Sale purchase of stock | 4.01M | 475.51M | - | - | - |
Other cashflows from financing activities | 116.97M | 1421.58M | 218.91M | 612.93M | 171.49M |
Change to netincome | 580.23M | 85.14M | 79.37M | 21.00M | 16.67M |
Capital expenditures | 12.01M | 15.95M | 15.24M | 16.64M | 19.58M |
Change receivables | -3.22700M | -8.80800M | - | - | - |
Cash flows other operating | 4.03M | 1.81M | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | -11.27300M | -106.85500M | - | - | - |
Change in working capital | -42.22300M | -71.32800M | 56.54M | 13.06M | 34.76M |
Stock based compensation | 15.89M | 14.43M | 3.27M | 1.95M | 2.12M |
Other non cash items | 601.26M | 125.89M | 90.06M | 26.70M | 23.56M |
Free cash flow | -60.41500M | -27.30000M | 101.38M | -25.35100M | 2.02M |
Sector: Healthcare Industry: Medical Care Facilities
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
AVAH Aveanna Healthcare Holdings Inc |
-0.12 2.36% | 4.96 | - | 60.61 | 0.51 | 1.17 | 1.15 | 17.51 |
HCA HCA Holdings Inc |
2.09 0.56% | 373.76 | 13.19 | 13.66 | 1.13 | 293.44 | 1.77 | 8.22 |
FSNUY Fresenius SE & Co KGaA ADR |
-0.01 0.08% | 12.80 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
JDHIY JD Health International Inc |
- -% | 5.10 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
JDHIF JD Health International Inc |
- -% | 3.23 | 57.75 | 32.68 | 0.29 | 2.11 | 0.16 | 3.90 |
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
400 Interstate North Parkway SE, Atlanta, GA, United States, 30339
Name | Title | Year Born |
---|---|---|
Mr. Rodney D. Windley | Exec. Chairman | 1948 |
Mr. Tony Strange | CEO & Director | 1963 |
Mr. David Afshar CPA | Chief Financial Officer | 1972 |
Mr. Jeffrey Shaner | Chief Operating Officer | 1973 |
Mr. Shannon L. Drake | Gen. Counsel & Chief Legal Officer | 1976 |
Mr. Ed Reisz | Chief Admin. Officer | 1959 |
Mr. Patrick A. Cunningham | Chief Compliance Officer | 1956 |
Ms. Beth Rubio | Chief Clinical Officer | 1957 |
Ms. Korey Hinz | Pres of Medical Solutions | NA |
Mr. Robert Radics | Pres of Home Health & Hospice | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.